Private Shareholders

If you have any question after the Sanofi General Meeting held on April 30, 2024, you can contact us from Monday to Friday from 9am to 6pm (free call from a landline in France)
Tel: 0 800 800 826.

Being a shareholder

As a Sanofi shareholder, you own a share in our capital, providing us with the resources we need to grow.
By investing in our future, you are giving us a vote of confidence. Confidence is the cornerstone of the special relationship between us and our shareholders. We are committed to retaining and building your confidence by involving you in our development and giving you a share of our profits.

Press Release of the first quarter of 2024, on April 25th:

“We are off to an excellent start in 2024, delivering on our strategic priorities and a transformation of our portfolio of medicines and vaccines to become a development-driven, tech-powered biopharma company committed to serving patients and accelerating growth. Continued strong performance by Dupixent and our new launches drove sales growth of seven percent. In parallel, we are delivering on our promise of increased investments in our late-stage pipeline to fully realize its value for patients and Sanofi. We are awaiting regulatory decisions for Dupixent in COPD, a progressive disease with limited effective treatment options. If approved, Dupixent will be the first biologic treatment in COPD. With the robust progress in our portfolio transformation, we reaffirm our financial guidance for 2024.”

Paul Hudson, Chief Executive Officer

Little Moments Brought to You by Big Science

We chase the miracles of science to improve people’s lives.

How to hold Sanofi shares

Sanofi ordinary shares can be held as:

  • Bearer shares: deposited with your financial intermediary,
  • Administered registered shares: deposited with your financial intermediary and recorded in the books of Sanofi,
  • Fully registered shares: deposited with and administered by Uptevia, transfer agent appointed by Sanofi. You benefit in this case from preferential rates for brokerage fees & bank commission and double voting rights when you have held your shares for at least two years
Various forms of your share’s ownership
Fully RegisteredAdministered RegisteredBearer
Buy or sell Sanofi shares
With Uptevia
With your financial intermediary
Hold shares in a single securities account
Custody and administration fees
According to your financial intermediary
Brokerage fee and bank commission
Preferential rates
According to your financial intermediary
Invitation to general meetings
Automatic sending by Uptevia
You must contact your financial intermediary
Voting rights
Double voting rights once you have held your shares for at least two years
One vote for each share held
Paid by Uptevia
Paid by your financial intermediary
Tax reporting form
Sent by Uptevia for your Sanofi shares only
Sent by your financial intermediary for all your shares

Uptevia fees for holding pure registered securities:

  • Free custody and administration fees
  • Bank commission of 7.62 euros per order
  • Brokerage fee: 0.45% with a minimum of 6.10 euros per order

Uptevia contact details

In-depth reading


Shares and ADRs

Shareholding structure


Sanofi Individual Shareholders Relations team

For all individual shareholders enquiries, you can write at:

Mail: relations.actionnaires (at) 

46 avenue de la Grande Armée
75017 Paris


All shareholders who hold registered shares can directly contact Uptevia, the bank administrating the registered shares program, for questions related to the management of their shares.


Managing shares on the Planetshares website: the access ID and password are sent to you at the opening of your registered shares account.


Tel, toll-free when calling from France:
0 800 87 74 32 (from 8:45 a.m to 6:00 p.m, Monday to Friday)
Tel for international callers: +33 (0)1 40 14 80 40

Actionnariat Sanofi
Corporate Trust Services - Services aux émetteurs
La Défense
Cœur Défense Tour A
90 - 110 Esplanade du Général de Gaulle
92931 Paris La Défense Cedex

JP Morgan Chase Bank, N.A. 

US shareholders or people interested in our American Depositary Receipts (ADR) program can contact our team in the United States.


Toll-free number in the U.S.: (1) 877 272 9475
For international callers: (1) 651 453 2128


Regular correspondence:
JPMorgan Chase Bank, NA
P.O. BOX 64504
St. Paul, MN 55164-0504

Delivery of stock certificates and overnight mail:
JPMorgan Chase Bank, NA
1110 Centre Pointe Curve, suite 101
Mendota Heights, MN 55120-4100

General inquiries concerning ADRs:
JPMorgan Chase Bank, NA
American Depositary Receipts
383 Madison Avenue, Floor 11
New York, NY 10179 - USA


Sanofi’s Group Savings Plan is managed by Amundi, which is also the contact for employee shareholders to answer questions about their employee savings and to process their requests.



Tel: 33 4 37 53 60 47

Amundi ESR 26956 
Valence Cedex 9